AUGMEDIX INC (AUGX) Stock Price & Overview

NASDAQ:AUGXUS05105P1075

Current stock price

2.35 USD
0 (0%)
At close:
2.35 USD
0 (0%)
After Hours:

The current stock price of AUGX is 2.35 USD. Today AUGX is down by 0%. In the past month the price increased by 1.73%. In the past year, price decreased by -53.47%.

AUGX Key Statistics

52-Week Range0.73 - 6.25
Current AUGX stock price positioned within its 52-week range.
1-Month Range2.31 - 2.35
Current AUGX stock price positioned within its 1-month range.
Market Cap
116.161M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.44
Dividend Yield
N/A

AUGX Stock Performance

Today
0%
1 Week
+0.43%
1 Month
+1.73%
3 Months
+135.00%
Longer-term
6 Months -41.69%
1 Year -53.47%
2 Years +58.78%
3 Years -37.33%
5 Years N/A
10 Years N/A

AUGX Stock Chart

AUGMEDIX INC / AUGX Daily stock chart

AUGX Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to AUGX. When comparing the yearly performance of all stocks, AUGX is one of the better performing stocks in the market, outperforming 90.44% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AUGX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AUGX. Both the profitability and financial health of AUGX have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AUGX Earnings

On August 12, 2024 AUGX reported an EPS of -0.13 and a revenue of 13.66M. The company beat EPS expectations (4.41% surprise) and missed revenue expectations (-1.76% surprise).

Next Earnings DateNov 4, 2024
Last Earnings DateAug 12, 2024
PeriodQ2 / 2024
EPS Reported-$0.13
Revenue Reported13.664M
EPS Surprise 4.41%
Revenue Surprise -1.76%

AUGX Forecast & Estimates

10 analysts have analysed AUGX and the average price target is 3.6 USD. This implies a price increase of 53% is expected in the next year compared to the current price of 2.35.

For the next year, analysts expect an EPS growth of -20.13% and a revenue growth 18.97% for AUGX


Analysts
Analysts80
Price Target3.6 (53.19%)
EPS Next Y-20.13%
Revenue Next Year18.97%

AUGX Groups

Sector & Classification

Index Membership

AUGX Financial Highlights

Over the last trailing twelve months AUGX reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS increased by 15.66% compared to the year before.


Income Statements
Revenue(TTM)51.59M
Net Income(TTM)-23.85M
Industry RankSector Rank
PM (TTM) N/A
ROA -44.44%
ROE -227.72%
Debt/Equity 1.48
Chartmill High Growth Momentum
EPS Q2Q%-8.33%
Sales Q2Q%26.75%
EPS 1Y (TTM)15.66%
Revenue 1Y (TTM)39.34%

AUGX Ownership

Ownership
Inst Owners72.68%
Shares49.43M
Float48.69M
Ins Owners11.72%
Short Float %N/A
Short RatioN/A

About AUGX

Company Profile

AUGX logo image Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 1,430 full-time employees. The company went IPO on 2021-03-04. The firm uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. The company also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.

Company Info

IPO: 2021-03-04

AUGMEDIX INC

111 Sutter Street, Suite 1300

San Francisco CALIFORNIA US

CEO: Emmanuel Krakaris

Employees: 1430

AUGX Company Website

Phone: 15619892208

AUGMEDIX INC / AUGX FAQ

Can you describe the business of AUGMEDIX INC?

Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 1,430 full-time employees. The company went IPO on 2021-03-04. The firm uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. The company also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.


What is the stock price of AUGMEDIX INC today?

The current stock price of AUGX is 2.35 USD.


Does AUGMEDIX INC pay dividends?

AUGX does not pay a dividend.


How is the ChartMill rating for AUGMEDIX INC?

AUGX has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists AUGX stock?

AUGX stock is listed on the Nasdaq exchange.


What is the GICS sector and industry of AUGX stock?

AUGMEDIX INC (AUGX) operates in the Health Care sector and the Health Care Technology industry.


What is AUGMEDIX INC worth?

AUGMEDIX INC (AUGX) has a market capitalization of 116.16M USD. This makes AUGX a Micro Cap stock.